E-LIB Suche - Ergebnisse für: Due, Hanne

1

CRISPR-Cas9 Knockout Screens Identify DNA Damage Response P..:

Issa, Issa Ismail ; Due, Hanne ; Brøndum, Rasmus Froberg...
Cancers. 16 (2024) 13 - p. 2437 , 2024

2

Hsp90 inhibition sensitizes DLBCL cells to cisplatin:

Schmidt, Linnéa ; Issa, Issa Ismail ; Haraldsdóttir, Hulda...
Cancer Chemotherapy and Pharmacology. 89 (2022) 4 - p. 431-440 , 2022

Link: https://doi.org/10.1007/..

3

MicroRNAs associated to single drug components of R-CHOP id..:

Due, Hanne ; Brøndum, Rasmus Froberg ; Young, Ken H...
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

4

Identification of BLNK and BTK as mediators of rituximab‐in..:

Thomsen, Emil Aagaard ; Rovsing, Anne Bruun ; Anderson, Mads Valdemar...
Molecular Oncology. 14 (2020) 9 - p. 1978-1997 , 2020

Link: https://doi.org/10.1002/..

5

Expression of NOTCH3 exon 16 differentiates Diffuse Large B..:

Jespersen, Ditte Starberg ; Schönherz, Anna A. ; Due, Hanne...
Scientific Reports. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

6

MicroRNA-155 controls vincristine sensitivity and predicts ..:

Due, Hanne ; Schönherz, Anna Amanda ; Ryø, Laura...
Blood Advances. 3 (2019) 7 - p. 1185-1196 , 2019

Link: https://doi.org/10.1182/..

7

High CXCR4 expression impairs rituximab response and the pr..:

Bach Laursen, Maria ; Reinholdt, Linn ; Schönherz, Anna Amanda...
Oncotarget. 10 (2019) 7 - p. 717-731 , 2019

Link: https://doi.org/10.18632..

8

Aspects of vincristine-induced neuropathy in hematologic ma..:

Madsen, Marie Lindhard ; Due, Hanne ; Ejskjær, Niels...
Cancer Chemotherapy and Pharmacology. 84 (2019) 3 - p. 471-485 , 2019

Link: https://doi.org/10.1007/..

9

A multiple myeloma classification system that associates no..:

Bøgsted, Martin ; Dybkær, Karen ; El-Galaly, Tarec...
Blood Advances. 2 (2018) 18 - p. 2400-2411 , 2018

Link: https://doi.org/10.1182/..

10

Molecular classification of tissue from a transformed non-H..:

Bødker, Julie Støve ; Severinsen, Marianne Tang ; El-Galaly, Tarec Christoffer...
Experimental Hematology & Oncology. 6 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

11

miR-155 as a Biomarker in B-Cell Malignancies:

Due, Hanne ; Svendsen, Pernille ; Bødker, Julie Støve...
BioMed Research International. 2016 (2016) - p. 1-14 , 2016

Link: https://doi.org/10.1155/..

12

Hsp90 inhibition sensitizes DLBCL cells to cisplatin:

Schmidt, Linnéa ; Issa, Issa Ismail ; Haraldsdóttir, Hulda...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956557/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Hsp90 inhibition sensitizes DLBCL cells to cisplatin:

Schmidt, Linnéa ; Issa, Issa Ismail ; Haraldsdóttir, Hulda...
https://vbn.aau.dk/da/publications/751137a7-ceb5-4fdb-8201-9ddc087030b3. , 2022

Link: https://vbn.aau.dk/da/pu..

14

A bendamustine resistance gene signature in diffuse large B..:

Issa, Issa Ismail ; Brøndum, Rasmus Froberg ; Due, Hanne...
https://vbn.aau.dk/da/publications/292bea4e-d6d4-4089-9af2-68f25bef7a83. , 2021

Link: https://vbn.aau.dk/da/pu..

15

Identification of BLNK and BTK as mediators of rituximab‐in..:

Thomsen, Emil Aagaard ; Rovsing, Anne Bruun ; Anderson, Mads Valdemar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463323/. , 2020

Link: http://www.ncbi.nlm.nih...